Abstract:Gossypol, a polyphenolic aldehyde derived from cottonseed plants, has seen a transformation in its pharmaceutical application from a male contraceptive to a candidate for cancer therapy. This shift is supported by its recognized antitumor properties, which have prompted its investigation in the treatment of various cancers and related inflammatory conditions. This review synthesizes the current understanding of gossypol as an anticancer agent, focusing on its pharmacological mechanisms, strategies to enhance its clinical efficacy, and the status of ongoing clinical evaluations.The methodological approach to this review involved a systematic search across several scientific databases including the National Center for Biotechnology Information (NCBI), PubMed/MedLine, Google Scholar, Scopus, and TRIP. Studies were meticulously chosen to cover various aspects of gossypol, from its chemical structure and natural sources to its pharmacokinetics and confirmed anticancer efficacy. Specific MeSH terms and keywords related to gossypol's antineoplastic applications guided the search strategy.Results from selected pharmacological studies indicate that gossypol inhibits the Bcl-2 family of anti-apoptotic proteins, promoting apoptosis in tumor cells. Clinical trials, particularly phase I and II, reveal gossypol's promise as an anticancer agent, demonstrating efficacy and manageable toxicity profiles. The review identifies the development of gossypol derivatives and novel carriers as avenues to enhance therapeutic outcomes and mitigate adverse effects.Conclusively, gossypol represents a promising anticancer agent with considerable therapeutic potential. However, further research is needed to refine gossypol-based therapies, explore combination treatments, and verify their effectiveness across cancer types. The ongoing clinical trials continue to support its potential, suggesting a future where gossypol could play a significant role in cancer treatment protocols.

[The Anti-Reproductive Active Compound Gossypol: Progress in Research].

Recent progress in gossypol derivatives and their structure-activity relationship

Natural Product Gossypol and Its Derivatives in Precision Cancer Medicine

Structure, Properties of Gossypol and Its Derivatives—from Physiological Activities to Drug Discovery and Drug Design

Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases

The potential roles of gossypol as anticancer agent: advances and future directions

Recent advances in gossypol derivatives and analogs: a chemistry and biology view.

Identification of the gossypol derivatives as androgen receptor inhibitor

Progresses on the Gossypol’s Chemical Structure

Bioactivities of gossypol, 6-methoxygossypol, and 6,6'-dimethoxygossypol.

Inhibition Of Proliferation Of Prostate Cancer Cell Line, Pc-3, In Vitro And In Vivo Using (-)-Gossypol

A New Antifertility Mechanism of Gossypol: Inhibition on Phospholipase

Gossypol Biosynthesis in Cotton Revealed Through Organ Culture, Plant Grafting and Gene Expression Profiling

Zero-Order Release of Gossypol Improves Its Antifertility Effect and Reduces Its Side Effects Simultaneously

Inhibition of T-type Ca2+ currents in mouse spermatogenic cells by gossypol, an antifertility compound

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity As an Inhibitor of Antiapoptotic Proteins.

Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma

Gossypin: A flavonoid with diverse pharmacological effects

Synthesis and antiviral, insecticidal, and fungicidal activities of gossypol derivatives containing alkylimine, oxime or hydrazine moiety

Suppression of LPS-induced Inflammatory Responses by Gossypol in RAW 264.7 Cells and Mouse Models.

A Novel Water-Soluble Gossypol Derivative Increases Chemotherapeutic Sensitivity and Promotes Growth Inhibition in Colon Cancer